Content about Chemistry

October 10, 2013

A subsidiary of Johnson & Johnson has acquired rights to an experimental drug for hepatitis C from GlaxoSmithKline.

TITUSVILLE, N.J. — A subsidiary of Johnson & Johnson has acquired rights to an experimental drug for hepatitis C from GlaxoSmithKline.

Janssen Pharmaceuticals announced that it had bought, for an undisclosed among, the drug GSK2336805 from GSK. The drug, which belongs to a class known as NS5a replication complex inhibitors, is currently in mid-stage development.

October 10, 2013

Over the past century, women have come to recognize the famous Nivea crème tin. Now, the iconic tin has taken on a new form and served as the inspiration for the redesigned packaging across all of theNivea products.

NEW YORK — Over the past century, women have come to recognize the famous Nivea crème tin. Now, the iconic tin has taken on a new form and served as the inspiration for the redesigned packaging across all of theNivea products. During a recent press event in New York City featuring celebrity stylist Phillip Bloch, the skin care brand celebrated the new “design language,” which is designed to help unify the look and feel of Nivea — making it more prominent and easily recognizable at shelf.

October 9, 2013

The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

SILVER SPRING, Md. — The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

October 8, 2013

Lupin Pharmaceuticals announced today that it has launched its generic gatifloxacin ophthalmic solution 0.5%. Lupin had earlier received final approval from the Food and Drug Administration to market a generic version of Allergan's Zymaxid ophthalmic solution, 0.5%, which is indicated for the treatment of bacterial conjunctivitis.

BALTIMORE — Lupin Pharmaceuticals announced today that it has launched its generic gatifloxacin ophthalmic solution 0.5%. Lupin had earlier received final approval from the Food and Drug Administration to market a generic version of Allergan's Zymaxid ophthalmic solution, 0.5%, which is indicated for the treatment of bacterial conjunctivitis.

October 7, 2013

Represented by the Greenwood Group, Smith Brothers is making its way back onto shelves with a new way of thinking about sore throat lozenges, according to a report published Friday by Bloomberg.

NEW YORK — Represented by the Greenwood Group, Smith Brothers is making its way back onto shelves with a new way of thinking about sore throat lozenges, according to a report published Friday by Bloomberg. 

October 3, 2013

The Food and Drug Administration is requiring Johnson & Johnson to use long-lasting ink in the labeling and dosage strength of an opioid painkiller patch it markets in order to make it easier to see.

SILVER SPRING, Md. — The Food and Drug Administration is requiring Johnson & Johnson to use long-lasting ink in the labeling and dosage strength of an opioid painkiller patch it markets in order to make it easier to see.

October 3, 2013

A patient may be able to eat all of the ice cream he wants after having his tonsils removed, but researchers at Henry Ford Hospital in Detroit say he doesn't necessarily need a prescription to reduce post-operative pain — an over-the-counter pain reliever is just as effective.

DETROIT — A patient may be able to eat all of the ice cream he wants after having his tonsils removed, but researchers at Henry Ford Hospital in Detroit say he doesn't necessarily need a prescription to reduce post-operative pain — an over-the-counter pain reliever is just as effective.

The study released Monday found over-the-counter ibuprofen manages pain after a tonsillectomy for children and adults, as well as the prescription pain medications acetaminophen with hydrocodone and acetaminophen with codeine, which is no longer recommended for use in children.

October 1, 2013

The Food and Drug Administration has approved a new drug developed by Takeda to treat major depressive disorder, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug developed by Takeda to treat major depressive disorder, the agency said.

The FDA announced the approval of Brintellix (vortioxetine) tablets for treating MDD in adults. The drug will be available in the 5-mg, 10-mg, 15-mg and 20-mg strengths.

September 30, 2013

Amneal Pharmaceuticals has bought rights to four generic drugs from Actavis, Amneal said Monday.

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has bought rights to four generic drugs from Actavis, Amneal said Monday.

September 26, 2013

Shea butter is renowned for its moisturizing benefits and its power to improve the lives of women in West Africa, where women are solely responsible for the harvesting of the ingredient. KAO USA’s Jergens skin care has stressed its commitment to uplifting these women and their families by purchasing the shea butter from them and infusing it the new Jergens Shea Butter collection.

NEW YORK — Shea butter is renowned for its moisturizing benefits and its power to improve the lives of women in West Africa, where women are solely responsible for the harvesting of the ingredient. KAO USA’s Jergens skin care has stressed its commitment to uplifting these women and their families by purchasing the shea butter from them and infusing it the new Jergens Shea Butter collection.

September 26, 2013

Pharmagen on Thursday announced the launch of Clotamin, a unique multivitamin formulated without vitamin K in order to meet the special nutritional needs of people taking blood-thinning medications (anticoagulants), such as Warfarin.

SILVER SPRING, Md. — Pharmagen on Thursday announced the launch of Clotamin, a unique multivitamin formulated without vitamin K in order to meet the special nutritional needs of people taking blood-thinning medications (anticoagulants), such as Warfarin. 

Because it does not contain vitamin K, Clotamin can be taken with Warfarin without affecting international normalized ratio levels. 

September 25, 2013

The September/October 2013 Digestive Aids Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Tums Chewy Delights, Alka Seltzer Fruit Chews, Maximum Strength Zantac 150 Cool Mint, Maximum Strength Pepcid AC, Prilosec OTC (Wildberry Flavor), Prevacid 24 Hour, Zegerid OTC and Gas-X.

The September/October 2013 Digestive Aids Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Tums Chewy Delights, Alka Seltzer Fruit Chews, Maximum Strength Zantac 150 Cool Mint, Maximum Strength Pepcid AC, Prilosec OTC (Wildberry Flavor), Prevacid 24 Hour, Zegerid OTC and Gas-X.

Click here for the complete guide.

September 25, 2013

Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.

PITTSBURGH — Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.

Mylan said Wednesday that Forest Labs and Royalty Pharma had sued it in the U.S. District Court for the District of Delaware in connection with its filing of a regulatory approval application with the Food and Drug Administration for milnacipran hydrochloride tablets in the 12.5-mg, 25-mg, 50-mg and 100-mg strengths. The drug is a generic version of Savella.

September 24, 2013

Abbott on Tuesday introduced a new nutrition shake called Glucerna Advance — formulated for people with diabetes who are seeking additional nutrition and health benefits.

ABBOTT PARK, Ill. — Abbott on Tuesday introduced a new nutrition shake called Glucerna Advance — formulated for people with diabetes who are seeking additional nutrition and health benefits. The new product helps to minimize blood sugar spikes while supporting heart hearth and the immune system, Abbott noted. 

September 24, 2013

The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.

STAMFORD, Conn. — The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.

Purdue announced the approval of the 15-microgram-per-hour strength of Butrans (buprenorphine). The drug is used to treat moderate to severe chronic pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. The new strength is in addition to the 5-microgram, 10-microgram and 20-microgram strengths already on the market, and it will be launched next month.

September 24, 2013

The global market for Type 2 diabetes will nearly double over the next six years, according to a new report.

NEW YORK — The global market for Type 2 diabetes will nearly double over the next six years, according to a new report.

GBI Research announced the release of a study Tuesday indicating that the market will grow from 2012's $20.4 billion to $38.8 billion by 2019, at an annual growth rate of 10.2%. The United States' market, meanwhile, will more than double, from $12.7 billion last year to $27.2 billion in 2019.

September 23, 2013

A report funded by a Council for Responsible Nutrition Foundation grant made the case for supplementation as a key component in any healthcare cost reduction strategy. It's not news to those in the industry who already know the health benefits associated with supplementation. But for the consumer media so quick to run a negative headline, this may come as a bit of a shock.

Here's the secret. Dietary supplements are not only a part of a healthy diet, they also beget healthier behaviors. And America is at the precipice of becoming a whole lot more interested in healthier behaviors. After all, the cost burden shift from the employer to the consumer will only continue. And as consumers assume more and more of those healthcare costs, reports like this will help make the case that supplementation is worth a look as a cost containment tool.

A report funded by a Council for Responsible Nutrition Foundation grant made the case for supplementation as a key component in any healthcare cost reduction strategy. It's not news to those in the industry who already know the health benefits associated with supplementation. But for the consumer media so quick to run a negative headline, this may come as a bit of a shock. 

September 23, 2013

The Food and Drug Administration has approved a drug made by Perrigo Co. for treating heart disease, the company said Monday.

ALLEGAN, Mich. — The Food and Drug Administration has approved a drug made by Perrigo Co. for treating heart disease, the company said Monday.

The FDA approved Perrigo's nitroglycerin lingual spray in the 400-mcg-per-spray strength. The drug is used to relieve attacks of or prevent angina pectoris due to coronary artery disease.

September 23, 2013

St. Joseph Health Products was honored with "Best New Product" distinction here by retailers attending the ECRM Health Care EPPS.

 PALM BEACH GARDENS, Fla. — St. Joseph Health Products was honored with "Best New Product" distinction here by retailers attending the ECRM Health Care EPPS. 

The new product is St. Joseph Rapid Dissolving Melts low-dose aspirin, a new delivery format that will hold appeal among pill-phobic seniors looking to take a low-dose aspirin daily for heart health. 

September 23, 2013

Teva Pharmaceutical Industries has launched a generic drug for treating cardiovascular disease, the company said.

JERUSALEM — Teva Pharmaceutical Industries has launched a generic drug for treating cardiovascular disease, the company said.

Teva announced the launch of niacin extended-release tablets in the 500-mg, 750-mg and 1,000-mg strengths. As the first company to file for approval of the drug, Teva will have 180 days in which to market the generic version exclusively.

September 19, 2013

Prestige Brands released PediaCare Single Dose Acetaminophen Fever Reducer/Pain Reliever — the only pre-measured acetaminophen in individual, squeezable packets perfect for anytime dosing, according to the company.

TARRYTOWN, N.Y. — Prestige Brands on Wednesday released PediaCare Single Dose Acetaminophen Fever Reducer/Pain Reliever — the only pre-measured acetaminophen in individual, squeezable packets perfect for anytime dosing, according to the company.

To help educate caregivers about the Single Dose product and offer tips on knowing when a child should be given acetaminophen, PediaCare has partnered with father and pediatrician, Dr. David Hill, author of Dad to Dad: Parenting like a Pro, to develop an informational video on the single dose product.

September 18, 2013

The Feel Good Vitamin Co. was launched Tuesday with the aim of helping end childhood malnutrition.

RALEIGH, N.C. — The Feel Good Vitamin Co. was launched Tuesday with the aim of helping end childhood malnutrition.  

September 18, 2013

Beiersdorf’s Nivea brand officially unveiled on Tuesday new packaging across all products inspired by the famous Nivea blue tin that women have come to recognize over the past century.

NEW YORK — Beiersdorf’s Nivea brand officially unveiled on Tuesday new packaging across all products inspired by the famous Nivea blue tin that women have come to recognize over the past century.

September 17, 2013

The Food and Drug Administration has approved a generic drug for insomnia made by Lupin, the drug maker said.

BALTIMORE — The Food and Drug Administration has approved a generic drug for insomnia made by Lupin, the drug maker said.

The FDA approved zolpidem tartrate extended-release tablets in the 6.25-mg and 12.5-mg strengths, a generic version of Sanofi's Ambien CR.

The branded version of the drug had sales of $366 million during the 12-month period ended in March, according to IMS Health.

 

September 17, 2013

The Food and Drug Administration has approved an injected drug for the bone marrow disorder myelodysplastic syndrome made by Dr. Reddy's Labs, the company said Tuesday.

HYDERABAD, India — The Food and Drug Administration has approved an injected drug for the bone marrow disorder myelodysplastic syndrome made by Dr. Reddy's Labs, the company said Tuesday.

Dr. Reddy's announced the approval of azacitidine injection in the 100-mg-per-vial strength. The drug is a generic version of Celgene's Vidaza, and Dr. Reddy's plans to launch the product in the near future.

Vidaza had sales of about $378.5 million during the 12-month period ended in July, according to IMS Health.